Atlas Trials

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans

Clinical trial NCT00625014 · COMPLETED

Trial details

NCT number
NCT00625014
Sponsor
Leiden University Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Insulin ResistanceDyslipidemia
Start date
2005-03-01
Primary completion
2005-07-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.